Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP).

Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis examines the clinical research evidence on the safety and effects of fecal transplantation in the treatment of patients with Clostridium difficile-associated disease and/or ulcerative colitis. It also provides information on the prevalence and incidence of the two diseases and the availability of fecal transplantation procedure in Alberta and Canada. The Institute of Health Economics prepared this STE report at the request of the Government of Alberta as part of the Institute’s ongoing work to support the Alberta Health Technologies Decision Process.

Information Specialist: Diane Lorenzetti